Populations of almost every country will see growth in the proportion of older persons throughout the coming decades. Life spans for those over age 65 continue to rise throughout the world. Such growth will have major impacts on economics, politics, and health care. In the USA, the population over age 65 and especially that over 85 years will increase rapidly through 2050. Most older persons will remain at home, but those with increasing functional limitations will seek assisted living or long-term care facilities. Those in long-term care will demonstrate multiple diseases and perhaps 50 % will have some dementia. Since urologists treat many diseases of older adults, including prostatic obstruction, genitourinary cancers, incontinence, and others, they will encounter a growing number of these elderly patients in their practices. Hence, there is a need for urologists to acquire basic knowledge in care of the geriatric patient just as, in the past, they have done for the pediatric patient. As a result of this increasing emphasis on geriatric care in urology, the American Urological Association included a chapter on Geriatric Urology in its latest online curriculum for urology, especially since the American Board of Urology and the Residency Review Committee for Urology both require geriatrics as a core area of knowledge for residency education and Board certification.
Prostate Cancer Bladder Cancer Urinary Incontinence Pelvic Organ Prolapse Lower Urinary Tract Symptom
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Older Americans 2010: Key Indicators of Well Being. Federal interagency forum on aging related statistics. http://www.agingstats.gov (2012). Accessed 11 Jan 2012.
Wei J, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256–61.PubMedCrossRefGoogle Scholar
Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006;175:S19–24.PubMedCrossRefGoogle Scholar
McNicholas T, Kirby R. Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). Clin Evid (Online). 2011;2011:1801. Accessed 22 Nov 2011.Google Scholar
Guzzo TJ, Drach GW. Major urologic problems in geriatrics: assessment and management. Med Clin North Am. 2011;95:253–64.PubMedCrossRefGoogle Scholar
Medicare leading part B procedure codes based on allowed charges, calendar year 2005. http://www.cms.gov 2011. Accessed 23 Apr 2011.
Djavan B, Kazzazi A, Bostanci Y. Revival of thermotherapy for benign prostatic hyperplasia. Curr Opin Urol. 2011;22(1):16–21. Accessed 22 Nov 2011.CrossRefGoogle Scholar
Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am. 2011;95:87–100.PubMedCrossRefGoogle Scholar
Li C, Ekwueme DU, Rim SH, Tangka FK. Years of potential life lost and productivity losses from male urogenital cancer deaths – United States 2004. Urology. 2010;76:528–35.PubMedCrossRefGoogle Scholar
Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40:IV-104–17.CrossRefGoogle Scholar
Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive services task force. Ann Intern Med. 2011;155(11):762–71. Accessed 22 Nov 2011.PubMedCrossRefGoogle Scholar
McNaughton-Collins MF, Barry MJ. One man at a time – resolving the PSA controversy. N Engl J Med. 2011;365:1951–3.PubMedCrossRefGoogle Scholar
Shariat SF, Sfakianos JP, Droller MJ, et al. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010;105:300–8.PubMedCrossRefGoogle Scholar
Liberman D, Lughezzani G, Sun M, et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011;77:660–6.PubMedCrossRefGoogle Scholar
Chang SS, Alberts G, Cookson MS, et al. Radical cystectomy is safe in elderly patients at high risk. J Urol. 2001;166:938–40.PubMedCrossRefGoogle Scholar
Hollenbeck BK, Miller DC, Taub D, et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology. 2004;64:292–9.PubMedCrossRefGoogle Scholar
Linehan WM. Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics. Genome Res. 2012;22(11):2089–100. Accessed 31 Oct 2012.PubMedCentralPubMedCrossRefGoogle Scholar
Hollenbeak CS, Nikkel LE, Schaefer EW, et al. Determinants of Medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm. 2011;17:610–20.PubMedCentralPubMedGoogle Scholar